Molecular characterization of vaginal microbiota using a new 22-species qRT-PCR test to achieve a relative-abundance and species-based diagnosis of bacterial vaginosis
Frontiers in Cellular and Infection Microbiology · 2024
DOI: 10.3389/fcimb.2024.1409774 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Ayodeji B Oyenihi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Biomarker Research, Medical Diagnostic Laboratories, Genesis Biotechnology Group, Hamilton, NJ, United States. Hauptthemen laut MEDLINE: Vaginosis, Bacterial, Vagina, Microbiota, Lactobacillus. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Numerous bacteria are involved in the etiology of bacterial vaginosis (BV). Yet, current tests only focus on a select few. We therefore designed a new test targeting 22 BV-relevant species.
Methods
Using 946 stored vaginal samples, a new qPCR test that quantitatively identifies 22 bacterial species was designed. The distribution and relative abundance of each species, α- and β-diversities, correlation, and species co-existence were determined per sample. A diagnostic index was modeled from the data, trained, and tested to classify samples into BV-positive, BV-negative, or transitional BV.
Results
The qPCR test identified all 22 targeted species with 95 – 100% sensitivity and specificity within 8 hours (from sample reception). Across most samples, Lactobacillus iners, Lactobacillus crispatus, Lactobacillus jensenii, Gardnerella vaginalis, Fannyhessea (Atopobium) vaginae, Prevotella bivia , and Megasphaera sp. type 1 were relatively abundant. BVAB-1 was more abundant and distributed than BVAB-2 and BVAB-3. No Mycoplasma genitalium was found. The inter-sample similarity was very low, and correlations existed between key species, which were used to model, train, and test a diagnostic index: MDL-BV index . The MDL-BV index , using both species and relative abundance markers, classified samples into three vaginal microbiome states. Testing this index on our samples, 491 were BV-positive, 318 were BV-negative, and 137 were transitional BV. Although important differences in BV status were observed between different age groups, races, and pregnancy status, they were statistically insignificant.
Conclusion
Using a diverse and large number of vaginal samples from different races and age groups, including pregnant women, the new qRT-PCR test and MDL-BV index efficiently diagnosed BV within 8 hours (from sample reception), using 22 BV-associated species.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Biomarker Research, Medical Diagnostic Laboratories, Genesis Biotechnology Group, Hamilton, NJ, United States.
- Memorial Women's Care, Houston, TX, United States.
Zitieren
APA
Oyenihi, A. B., Haines, R., Trama, J., Faro, S., Mordechai, E., Adelson, M. E., & Osei Sekyere, J. (2024). Molecular characterization of vaginal microbiota using a new 22-species qRT-PCR test to achieve a relative-abundance and species-based diagnosis of bacterial vaginosis. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1409774
Vancouver
Oyenihi AB, Haines R, Trama J, Faro S, Mordechai E, Adelson ME, et al. Molecular characterization of vaginal microbiota using a new 22-species qRT-PCR test to achieve a relative-abundance and species-based diagnosis of bacterial vaginosis. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1409774
BibTeX
@article{Oyenihi2024,
author = {Oyenihi, Ayodeji B and Haines, Ronald and Trama, Jason and Faro, Sebastian and Mordechai, Eli and Adelson, Martin E and Osei Sekyere, John},
title = {Molecular characterization of vaginal microbiota using a new 22-species qRT-PCR test to achieve a relative-abundance and species-based diagnosis of bacterial vaginosis},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2024},
doi = {10.3389/fcimb.2024.1409774}
}
EUVIMED